[Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine].
Vopr Virusol
; 58(3): 28-31, 2013.
Article
em Ru
| MEDLINE
| ID: mdl-24006630
ABSTRACT
In the present work, the immunoadjuvant properties of the influenza deltaNS1 vaccine virus after intranasal administration in combination with recombinant GBS polypeptides was tested in mice. According to our data, co-administration of recombinant GBS polypeptides and influenza deltaNS1 vaccine resulted in the increase in the immunogenicity and protective efficacy of bacterial proteins. Combined vaccination with the GBS polypeptides and influenza deltaNS1 vaccine has a potential to be used not only for prophylaxis infections caused by SGB, but also for prevention of the bacterial complications of influenza.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções Estreptocócicas
/
Vacinas contra Influenza
/
Infecções por Orthomyxoviridae
/
Vacinas Estreptocócicas
/
Vírus da Influenza A Subtipo H1N1
/
Anticorpos Antibacterianos
/
Anticorpos Antivirais
Limite:
Animals
Idioma:
Ru
Revista:
Vopr Virusol
Ano de publicação:
2013
Tipo de documento:
Article